Valuation: Celltrion, Inc.

Capitalization 37,128B 26.11B 24.7B 22.9B 20.48B 36.91B 2,211B 40.86B 285B 105B 908B 98.07B 95.89B 3,914B P/E ratio 2024 *
85.2x
P/E ratio 2025 * 31.9x
Enterprise value 38.22B 26.87M 25.43M 23.57M 21.08M 37.99M 2.28B 42.06M 293M 108M 935M 101M 98.7M 4.03B EV / Sales 2024 *
11x
EV / Sales 2025 * 8.63x
Free-Float
66.5%
Yield 2024 *
0.28%
Yield 2025 * 0.28%
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Celltrion, Inc.

1 day-0.50%
1 week-3.38%
Current month-3.69%
1 month-2.33%
3 months-4.20%
6 months-5.36%
Current year-10.62%
More quotes
1 week
176 900.00
Extreme 176900
189 500.00
1 month
160 300.00
Extreme 160300
189 500.00
Current year
160 300.00
Extreme 160300
241 000.00
1 year
157 500.00
Extreme 157500
241 000.00
3 years
131 000.00
Extreme 131000
241 000.00
5 years
128 001.80
Extreme 128001.804
372 915.00
10 years
27 751.54
Extreme 27751.5426
372 915.00
More quotes
Director TitleAgeSince
Chief Executive Officer - 2015-03-19
Director of Finance/CFO 49 -
Compliance Officer 42 -
Manager TitleAgeSince
Chairman 67 -
Director/Board Member 66 2008-07-16
Director/Board Member 66 2008-07-16
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.50%-3.38%+10.76%-9.24%26.36B
+0.42%+0.35%+56.44%-27.31%42.72B
+1.35%+0.60%-5.45%-22.57%36.29B
+3.81%+2.18%-19.31%-20.29%17.3B
-1.26%-2.24%+53.83%+98.76%16.71B
+3.49%+2.42%-43.23%-85.51%16.52B
+0.84%-1.15%+15.73%-34.66%11.74B
+2.40%+3.41%+26.63%+70.04%10.62B
+0.14%-3.90%-3.29%-46.33%9.79B
-0.02%-0.75%+2.55%-22.29%9.65B
Average +0.89%-0.87%+9.47%-9.94% 19.77B
Weighted average by Cap. +0.87%-0.89%+14.20%-13.53%
See all sector performances

Financials

2024 *2025 *
Net sales 3,485B 2.45B 2.32B 2.15B 1.92B 3.46B 208B 3.84B 26.75B 9.89B 85.26B 9.2B 9B 367B 4,408B 3.1B 2.93B 2.72B 2.43B 4.38B 262B 4.85B 33.83B 12.51B 108B 11.64B 11.38B 465B
Net income 461B 325M 307M 285M 255M 459M 27.48B 508M 3.54B 1.31B 11.29B 1.22B 1.19B 48.65B 1,213B 853M 807M 748M 669M 1.21B 72.24B 1.33B 9.31B 3.44B 29.68B 3.2B 3.13B 128B
Net Debt 1,088B 765M 724M 671M 600M 1.08B 64.8B 1.2B 8.35B 3.09B 26.63B 2.87B 2.81B 115B 895B 629M 596M 552M 494M 890M 53.3B 985M 6.87B 2.54B 21.9B 2.36B 2.31B 94.36B
More financial data * Estimated data
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,391
More about the company
Date Price Change Volume
24-12-06 180,100.00 -0.50% 600,962
24-12-05 181,000.00 -1.09% 425,281
24-12-04 183,000.00 -2.09% 729,663
24-12-03 186,900.00 +1.25% 404,198
24-12-02 184,600.00 -1.28% 495,122

End-of-day quote Korea S.E., December 05, 2024

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C
surperformance-ratings-light-chart CELLTRION-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
180,100.00KRW
Average target price
246,952.38KRW
Spread / Average Target
+37.12%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock